|Bid||0.0770 x 250000|
|Ask||0.0800 x 1097400|
|Day's range||0.0760 - 0.0820|
|52-week range||0.0760 - 0.5350|
|Beta (5Y monthly)||1.08|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2023 - 27 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Some of the losses seen by insiders who purchased AU$895k worth of Exopharm Limited ( ASX:EX1 ) shares over the past...
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Exopharm Limited (ASX:EX1) has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).